Simian virus 40 large-T-antigen-specific rejection of mKSA tumor cells in BALB/c mice is critically dependent on both strictly tumor-associated, tumor-specific CD8+ cytotoxic T lymphocytes and CD4+ T helper cells

Journal of Virology

Volumn 75, Issue 22, 2001, Pages 10593-10602

  Utermohlen O ^a   Schulze Garg, C ^a   Warnecke, G ^a   Gugel, R ^a   Lohler J ^a   Deppert, W ^a  

^a Inst Med Mikrobiol Immunol/Hyg   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 2; MONOCLONAL ANTIBODY; TUMOR ANTIGEN; VIRUS LARGE T ANTIGEN;

ANIMAL CELL; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CELL ACTIVITY; CELL ISOLATION; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; HELPER CELL; IMMUNE RESPONSE; INOCULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIMIAN VIRUS 40; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, POLYOMAVIRUS TRANSFORMING; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; GRAFT REJECTION; IMMUNIZATION; IMMUNOTHERAPY; INTERFERON TYPE II; INTERLEUKIN-2; LYMPHOCYTE DEPLETION; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; SIMIAN VIRUS 40; T-LYMPHOCYTES, CYTOTOXIC; TUMOR VIRUS INFECTIONS;

EID: 0034761271     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.22.10593-10602.2001     Document Type: Article

References (54)

1. Comparison of the murine humoral immune response to recombinant simian virus 40 large tumor antigen: Epitope specificity and idiotype expression
2. Immunization of BALB/c mice with recombinant simian virus 40 large tumor antigen induces antibody-dependent cell-mediated cytotoxicity against simian virus 40-transformed cells. An antibody-based mechanism for tumor immunity
3. Examination of lymphokines induced in mice following immunization with recombinant simian virus 40 large tumor antigen
4. Protection against a lethal tumor challenge with SV40-transformed cells by the direct injection of DNA-encoding SV40 large tumor antigen
5. 51Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs
6. Coordinate regulation of complex T cell populations responding to bacterial infection
7. + T cells during an acute virus infection
8. Interferon: A cytotoxic T lymphocyte differentiation signal
9. Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo
10. Granulocyte colony-stimulating factor gene transfer suppresses tumorigenicity of a murine adenocarcinoma in vivo
11. Local cytokine availability elicits tumor rejection and systemic immunity through granulocyte-T-lymphocyte cross-talk
12. + MHC class II-restricted T cells that are cytolytic in vitro and tumoricidal in vivo
13. Control of acute infection with lymphocytic choriomeningitis virus in mice that cannot present an immunodominant viral cytotoxic T lymphocyte epitope
14. Obligatory role of IFN-γ in induction of lymphokine-activated and T lymphocyte killer activity, but not in boosting of natural cytotoxicity
15. Controlled release, biodegradable cytokine depots: A new approach in cancer vaccine design
16. Specificities of killing by cytotoxic lymphocytes generated in vivo and in vitro to syngeneic SV40 transformed cells
17. Specificities of Killing by T lymphocytes generated against syngeneic SV40 transformants: Studies empoying recombinants within the H-2 complex
18. Adoptive T cell therapy of tumors: Mechanisms operative in the recognition and elimination of tumor cells
19. Antigenic binding sites of monoclonal antibodies specific for simian virus 40 large T antigen
20. Mechanism and biological significance of CD4-mediated cytotoxicity
21. HLA class II-restricted T cell clones against a human sarcoma
22. Transplantable mouse tumor line induced by injection of SV40-transformed mouse kidney cells
23. Genetic control of the cytotoxic T cell response to SV40 tumor-associated specific antigen
24. Expression of simian virus 40 T antigen in insect cells: Using a baculovirus expression vector
25. + HLA-class I-restricted cytotoxic T cell clones with long-term assay and pretreatment of targets with interferon-γ
26. Gamma interferon-dependent clearance of cytomegalovirus infection in salivary glands
27. Tumor eradication by adoptive transfer of cytotoxic T lymphocytes
28. High gradient magnetic cell separation with MACS
29. Cytotoxicity of histocompatibility leukocyte antigen-DR8- restricted CD4 killer T cells against human autologous squamous cell carcinoma
30. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells
31. Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infection
32. + T cells as Th1 cells based on lymphokine secretion and functional properties
33. Role of a subdominant H-2Kd-restricted SV40 tumor antigen cytotoxic T lymphocyte epitope in tumor rejection
34. Antigenic properties of chemically induced tumors
35. + T helper cell responses in tumor immunity
36. Preferential H-2 association in cytotoxic T cell responses to SV40 tumor-associated specific antigens
37. CD4 monoclonal antibody pairs for immunosuppression and tolerance induction
38. Immunotherapy and gene therapy of cancer
39. Adoptive immunotherapy of established syngeneic solid tumors: Role of T lymphoid subpopulations
40. + T-cell induction of Fas-mediated apoptosis in Burkitt's lymphoma B cells
41. Immunization of mice with the N-terminal (1-272) fragment of simian virus 40 large T-antigen (without adjuvants) specifically primes cytotoxic T lymphocytes
42. d mice that reject syngeneic tumors
43. Antigen- and lectin-sensitized murine cytolytic T lymphocyte-precursors require both interleukin 2 and endogenously produced immune (γ) interferon for their growth and differentiation into effector cells
44. Collaboration of helper and cytotoxic T lymphocytes
45. Murine interleukin-4 displays potent anti-tumor activity in vivo
46. Recognition of simian virus 40 T antigen by cytotoxic T lymphocytes
47. +, class II MHC-restricted cytotoxic T cells
48. + T cells in cancer immunotherapy
49. T lymphocyte-mediated antiviral immune responses in mice are diminished by treatment with monoclonal antibody directed against the interleukin-2 receptor
50. Modulation by gamma interferon of antiviral cell-mediated immune responses in vivo
51. Quantitative contribution of CD4 and CD8 to T cell antigen receptor serial triggering
52. The role of T cells in allografted tumor rejection: IFN-γ released from T cells is essential for induction of effector macrophages in the rejection site
53. Elicitation of a systemic and protective anti-melanoma immune response by an IL-2-based vaccine. Assessment of critical cellular and molecular parameters
54. + T lymphocytes